SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Spekulatius who wrote (7877)2/17/2003 11:47:58 AM
From: Biomaven  Respond to of 52153
 
I recall a few years ago SUPG's Rubinfield, who used to be at Bristol, claiming that BMY's entire oncology product line was in-licensed.

The schizophrenia drug is licensed in, isn't it?
Yes, I belive this was developed by Otsuka.

Nevertheless, BMY is still interesting at these levels - if nothing else there's at least a reasonable chance that someone will munch them.

Peter